Hemophilia

The U.S. Food and Drug Administration today approved a new use for the blood product Kogenate FS to reduce the frequency of bleeding episodes and prevent joint damage in children with the most severe form of hemophilia.

Medications under investigation for safety issues revealed

The condition, which usually develops in adults, is known as chronic immune thrombocytopenic purpura (ITP), a disease that results in a low number of platelets...

When a small artery is cut, the collagen fibers in its tissue are exposed, which signals clotting process to begin.

NovoSeven RT Can Be Stored at Room Temperature

The U.S. Food and Drug Administration today licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.

The U.S. Food and Drug Administration today approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).

Users of the Freedom60 infusion pump from Repro-Med Systems Inc. DBA RMS Medical Products are now entitled to receive 20 times the Medicare reimbursement previously offered

FDA has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medication for patients' use in the home.

Individuals who receive home treatment include patients with infections that require intravenous (IV) medications, patients with cancer who need chemotherapy, and patients with severe pain who require intraspinal or IV medications.